Extracellular vesicles in neurodegenerative diseases

T Croese, R Furlan

Research output: Contribution to journalArticle

Abstract

Extracellular vesicles (EVs) are released by all neural cells, including neurons, oligodendrocytes, astrocytes, and microglia. The lack of adequate technology has not halted neuroscientists from investigating EVs as a mean to decipher neurodegenerative disorders, still in search of comprehensible pathogenic mechanisms and efficient treatment. EVs are thought to be one of ways neurodegenerative pathologies spread in the brain, but also one of the ways the brain tries to displace toxic proteins, making their meaning in pathogenesis uncertain. EVs, however do reach biological fluids where they can be analyzed, and might therefore constitute clinically decisive biomarkers for neurodegenerative diseases in the future. Finally, if they constitute a physiological inter-cell communication system, they may represent also a very specific drug delivery tool for a difficult target such as the brain. We try to resume here available information on the role of EVs in neurodegeneration, with a special focus on Alzheimer's disease, progressive multiple sclerosis, amyotrophic lateral sclerosis, and Huntington's disease. © 2017 Elsevier Ltd.
Original languageEnglish
Pages (from-to)52-61
Number of pages10
JournalMolecular Aspects of Medicine
Volume6
Issue number1
DOIs
Publication statusPublished - 2018

Fingerprint

Neurodegenerative diseases
Neurodegenerative Diseases
Brain
Poisons
Biomarkers
Pathology
Drug delivery
Neurons
Communication systems
Huntington Disease
Oligodendroglia
Amyotrophic Lateral Sclerosis
Microglia
Fluids
Cell Communication
Astrocytes
Multiple Sclerosis
Alzheimer Disease
Extracellular Vesicles
Proteins

Cite this

Extracellular vesicles in neurodegenerative diseases. / Croese, T; Furlan, R.

In: Molecular Aspects of Medicine, Vol. 6, No. 1, 2018, p. 52-61.

Research output: Contribution to journalArticle

@article{71c45d8fa4144887b66c7c312baffe24,
title = "Extracellular vesicles in neurodegenerative diseases",
abstract = "Extracellular vesicles (EVs) are released by all neural cells, including neurons, oligodendrocytes, astrocytes, and microglia. The lack of adequate technology has not halted neuroscientists from investigating EVs as a mean to decipher neurodegenerative disorders, still in search of comprehensible pathogenic mechanisms and efficient treatment. EVs are thought to be one of ways neurodegenerative pathologies spread in the brain, but also one of the ways the brain tries to displace toxic proteins, making their meaning in pathogenesis uncertain. EVs, however do reach biological fluids where they can be analyzed, and might therefore constitute clinically decisive biomarkers for neurodegenerative diseases in the future. Finally, if they constitute a physiological inter-cell communication system, they may represent also a very specific drug delivery tool for a difficult target such as the brain. We try to resume here available information on the role of EVs in neurodegeneration, with a special focus on Alzheimer's disease, progressive multiple sclerosis, amyotrophic lateral sclerosis, and Huntington's disease. {\circledC} 2017 Elsevier Ltd.",
author = "T Croese and R Furlan",
year = "2018",
doi = "10.1016/j.mam.2017.11.006",
language = "English",
volume = "6",
pages = "52--61",
journal = "Molecular Aspects of Medicine",
issn = "0098-2997",
publisher = "Elsevier Limited",
number = "1",

}

TY - JOUR

T1 - Extracellular vesicles in neurodegenerative diseases

AU - Croese, T

AU - Furlan, R

PY - 2018

Y1 - 2018

N2 - Extracellular vesicles (EVs) are released by all neural cells, including neurons, oligodendrocytes, astrocytes, and microglia. The lack of adequate technology has not halted neuroscientists from investigating EVs as a mean to decipher neurodegenerative disorders, still in search of comprehensible pathogenic mechanisms and efficient treatment. EVs are thought to be one of ways neurodegenerative pathologies spread in the brain, but also one of the ways the brain tries to displace toxic proteins, making their meaning in pathogenesis uncertain. EVs, however do reach biological fluids where they can be analyzed, and might therefore constitute clinically decisive biomarkers for neurodegenerative diseases in the future. Finally, if they constitute a physiological inter-cell communication system, they may represent also a very specific drug delivery tool for a difficult target such as the brain. We try to resume here available information on the role of EVs in neurodegeneration, with a special focus on Alzheimer's disease, progressive multiple sclerosis, amyotrophic lateral sclerosis, and Huntington's disease. © 2017 Elsevier Ltd.

AB - Extracellular vesicles (EVs) are released by all neural cells, including neurons, oligodendrocytes, astrocytes, and microglia. The lack of adequate technology has not halted neuroscientists from investigating EVs as a mean to decipher neurodegenerative disorders, still in search of comprehensible pathogenic mechanisms and efficient treatment. EVs are thought to be one of ways neurodegenerative pathologies spread in the brain, but also one of the ways the brain tries to displace toxic proteins, making their meaning in pathogenesis uncertain. EVs, however do reach biological fluids where they can be analyzed, and might therefore constitute clinically decisive biomarkers for neurodegenerative diseases in the future. Finally, if they constitute a physiological inter-cell communication system, they may represent also a very specific drug delivery tool for a difficult target such as the brain. We try to resume here available information on the role of EVs in neurodegeneration, with a special focus on Alzheimer's disease, progressive multiple sclerosis, amyotrophic lateral sclerosis, and Huntington's disease. © 2017 Elsevier Ltd.

U2 - 10.1016/j.mam.2017.11.006

DO - 10.1016/j.mam.2017.11.006

M3 - Article

VL - 6

SP - 52

EP - 61

JO - Molecular Aspects of Medicine

JF - Molecular Aspects of Medicine

SN - 0098-2997

IS - 1

ER -